In tumor‐bearing mice one week post‐treatment, miRNA treatment led to increased accumulation of CD4+ and CD8+ T cells (p<0.001) (Figure 5A) and decreased intertumoral Tregs (p<0.05) (Figure 5B). The gene discussed is CD8A; the disease is neoplasm.